Document:

Exhibit 10.11

   

  NEITHER
      THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
      OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
      (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
      UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
      OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
      EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

   

  COMMON
      STOCK PURCHASE WARRANT

   

  GZ6G TECHNOLOGIES
        CORP.

   

  Warrant
      Shares: 560,000

  Date
      of Issuance: November 10, 2021 (“Issuance Date”)

   

  This
      COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the execution
      of the Purchase Agreement (as defined below)), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered
      assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions
      hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from GZ6G Technologies Corp., a Nevada corporation
      (the “Company”), 560,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may
      be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This
      Warrant is issued by the Company as of the date hereof in connection with that certain equity purchase agreement dated November 10, 2021,
      by and among the Company and the Holder (the “Purchase Agreement”).

   

  Capitalized
      terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of this Warrant
      or in Section 12 below. For purposes of this Warrant, the term “Exercise Price” shall mean $1.00, subject to adjustment as
      provided herein (including but not limited to cashless exercise), and the term “Exercise Period” shall mean the period commencing
      on the Issuance Date and ending on 5:00 p.m. eastern standard time on the three-year anniversary thereof. 

   

  

  

   1. EXERCISE OF WARRANT.

   

  (a) Mechanics
        of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in whole or in
      part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit
        A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder shall not be
      required to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in
      purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
      number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before
      the second Trading Day (the “Warrant Share Delivery Date”) following the date on which the Holder sent the
      Exercise Notice to the Company or the Company’s transfer agent, and upon receipt by the Company of payment to the Company of
      an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which all or a portion of this
      Warrant is being exercised (the “Aggregate Exercise Price” and together with the Exercise Notice, the
      “Exercise Delivery Documents”) in cash or by wire transfer of immediately available funds (or by cashless
      exercise, in which case there shall be no Aggregate Exercise Price provided), the Company shall (or direct its transfer agent to)
      issue and deliver by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the
      Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the
      Holder is entitled pursuant to such exercise (or deliver such shares of Common Stock in electronic format if requested by the
      Holder). Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the
      holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
      of the certificates evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of
      Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon
      an exercise, then the Company shall as soon as practicable and in no event later than three business days after any exercise and at
      its own expense, issue a new Warrant (in accordance with Section 6) representing the right to purchase the number of Warrant Shares
      purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this
      Warrant isexercised.

   

  

  
  
    1

  

  
     

  

  
   

  If
      the Company fails to cause its transfer agent to issue to the Holder the respective shares of Common Stock by the respective Warrant
      Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion in addition to all
      other rights and remedies at law, under this Warrant, or otherwise, and such failure shall also be deemed a material breach under this
      Warrant and the Purchase Agreement.

   

  If
      the Market Price of one share of Common Stock is greater than the Exercise Price, then, unless there is an effective non-stale registration
      statement of the Company covering the Holder’s immediate resale of the Warrant Shares at prevailing market prices (and not fixed
      prices) without any limitation, the Holder may elect to receive Warrant Shares pursuant to a cashless exercise, in lieu of a cash exercise,
      equal to the value of this Warrant determined in the manner described below (or of any portion thereof remaining unexercised) by surrender
      of this Warrant and a Exercise Notice, in which event the Company shall issue to Holder a number of Common Stock computed using the following
      formula:

   

  X
      = Y (A-B) 

       A

   

  

  	 	Where	X = 	the number of Shares to be issued to Holder.

    

  

  		Y =	the number of Warrant Shares that the Holder elects to purchase
            under this Warrant (at the date of such calculation).

   

  

  		A =  	the Market Price (at the date of such calculation).

   

  

  		B =	Exercise Price (as adjusted to the date of such calculation).

   

  (b) No
        Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment pursuant
      hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
      whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
      of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
      a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

   

  
  
    2

  

  
     

  

  
   

  

  (c) Holder’s
        Exercise Limitations. Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise of
      this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 1 or otherwise, to
      the extent that after giving effect to such issuance after exercise as set forth on the applicable Exercise Notice, the Holder
      (together with the Holder’s affiliates (the “Affiliates”), and any other Persons acting as a group together
    with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own
    in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of
    Common Stock beneficially owned by the Holder and Attribution Parties shall include the number of shares of Common Stock issuable
    upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of
    Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by
    the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
    portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a
    limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
    Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 1(c), beneficial
    ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
    thereunder, it being acknowledged by the Holder that the Holder is solely responsible for any schedules required to be filed in
    accordance therewith. In addition, a determination as to any group status as contemplated above shall be determined in accordance
    with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(c), in
    determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
    as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a
    more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s transfer
    agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
    shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In
    any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
    securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which
    such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of
    the number of shares of the Common Stock outstanding at the time of the respective calculation hereunder. The limitations contained
    in this paragraph shall apply to a successor holder of this Warrant.

   

  (d) Compensation
        for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if
      the Company fails to cause the Company’s transfer agent to transmit to the Holder the Warrant Shares in accordance with the provisions
      of this Warrant (including but not limited to Section 1(a) above) pursuant to an exercise on or before the respective Warrant Share Delivery
      Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s
      brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
      the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder, within
      one (1) business day of Holder’s request, the amount, if any, by which (x) the Holder’s total purchase price (including brokerage
      commissions, if any) for the shares of Common Stock so purchased exceeds (y) the product of (1) the number of Warrant Shares that the
      Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving
      rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
      number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
      the Holder within one (1) business day of Holder’s request the number of shares of Common Stock that would have been issued had
      the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases, or effectuates
      a cashless exercise hereunder for, Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
      exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
      of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
      notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
      of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in
      equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure
      to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

   

  
  
    3

  

  
     

  

  
   

  

  2. ADJUSTMENTS.
      The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

   

  (a) Distribution
        of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets)
      to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation any distribution of cash,
      stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other similar
      transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case:

   

  (i) any
      Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of shares
      of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to
      a price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing Sale Price of the
      shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in
      good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator of which shall
      be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

   

  (ii) the
      number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately
      prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive
      the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided, however, that
      in the event that the Distribution is of shares of common stock of a company (other than the Company) whose common stock is traded on
      a national securities exchange or a national automated quotation system (“Other Shares of Common Stock”), then the
      Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares,
      the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the number of shares
      of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had the Holder exercised this
      Warrant immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise
      price of this Warrant was decreased with respect to the Distribution pursuant to the terms of the immediately preceding clause (i) and
      the number of Warrant Shares calculated in accordance with the first part of this clause (ii).

   

  (b) Anti-Dilution
        Adjustments to Exercise Price. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is
      outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or
      announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or securities (including but not
      limited to Common Stock Equivalents) entitling any person or entity (for purposes of clarification, including but not limited to the
      Holder pursuant to (i) any other security of the Company currently held by Holder or issued to Holder on or after the Issuance Date
      or (ii) any other agreement entered into between the Company and Holder (including but not limited to the Purchase Agreement)) to
      acquire shares of Common Stock (upon conversion, exercise or otherwise), at an effective price per share less than the then Exercise
      Price (such lower price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (if
      the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price
      adjustments, elimination of an applicable floor price for any reason in the future (including but not limited to the passage of time
      or satisfaction of certain condition(s)), reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to
      warrants, options or rights per share which are issued in connection with such issuance, be entitled or potentially entitled to
      receive shares of Common Stock at an effective price per share which is less than the Exercise Price at any time while such Common
      Stock or Common Stock Equivalents are in existence, such issuance shall be deemed to have occurred for less than the Exercise Price on
    such date of the Dilutive Issuance (regardless of whether the Common Stock or Common Stock Equivalents are (i)
      subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised at
      such Base Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base
      Share Price, and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable
      hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to
      such adjustment (for the avoidance of doubt, the aggregate Exercise Price prior to such adjustment is calculated as follows: the
      total number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such adjustment (without regard to the
      Beneficial Ownership Limitation) multiplied by the Exercise Price in effect immediately prior to such adjustment). By way of
      example, if E is the total number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such adjustment
      (without regard to the Beneficial Ownership Limitation), F is the Exercise Price in effect immediately prior to such adjustment, and
      G is the Base Share Price, the adjustment to the number of Warrant Shares can be expressed in the following formula: Total number of
      Warrant Shares after such Dilutive Issuance = the number obtained from dividing [E x F] by G. . Such adjustment shall be made
      whenever such Common Stock or Common Stock Equivalents are issued, regardless of whether the Common Stock or Common Stock
      Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually
      converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder may utilize the Base
      Share Price even if the Company did not actually issue shares of its common stock at the Base Share Price under the respective
      Common stock Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of
      any Common Stock or Common Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or
      applicable reset price, exchange price, conversion price and other pricing terms (such notice the “Dilutive Issuance
      Notice”). For purposes of clarification, regardless of whether (i) the Company provides a Dilutive Issuance Notice pursuant to
      this Section 2(b) upon the occurrence of any Dilutive Issuance or (ii) the Holder accurately refers to the Base Share Price in the
      Exercise Notice, the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price as well as the Base
      Share Price at all times on and after the date of such Dilutive Issuance. Notwithstanding the foregoing, no adjustment will be made
      under this Section 2(b) with respect to an Exempt Issuance (as defined below). An “Exempt Issuance” shall mean the
      issuance of (a) shares of Common Stock pursuant to the Company’s registration statement on Form S-1 that was declared
      effective by the SEC on September 27, 2021; or (b) shares of Common Stock pursuant to the conversion or exercise of Common Stock
      Equivalents issued by the Company prior to the Issuance Date (so long as the terms of such Common Stock Equivalents are not amended
      on or after the Issuance Date).

   

  

  
  
    4

  

  
     

  

  
   

  (c) Subdivision
        or Combination of Common Stock. If the Company at any time on or after the Issuance Date subdivides (by any stock split, stock dividend,
      recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise
      Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately
      increased. If the Company at any time on or after the Issuance Date combines (by combination, reverse stock split or otherwise) one or
      more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior
      to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment
      under this Section 2(c) shall become effective at the close of business on the date the subdivision or combination becomes effective.
      Each such adjustment of the Exercise Price shall be calculated to the nearest one-hundredth of a cent. Such adjustment shall be made
      successively whenever any event covered by this Section 2(c) shall occur.

   

  3. FUNDAMENTAL
        TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company with or into
      another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”), (ii)
      the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
      offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed
      pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities,
      cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iv) the Company effects any
      reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
      into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common
      Stock) (in any such case, a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the
      Holder shall have the right to receive the number of shares of Common Stock of the Successor Entity or of the Company and any
      additional consideration (the “Alternate Consideration”) receivable upon or as a result of such reorganization,
      reclassification, merger, consolidation or disposition of assets by a holder of the number of shares of Common Stock for which this
      Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise contained herein solely for the
      purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
      adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
      Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
      in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of
      Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the
      Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
      Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental
      Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right
      to exercise such warrant into Alternate Consideration.

   

  

  
  
    5

  

  
     

  

  
   

  4. NON-CIRCUMVENTION.
      The Company covenants and agrees that it will not, by amendment of its certificate of incorporation, bylaws or through any reorganization,
      transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
      avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out
      all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
      of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this
      Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the
      Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant, and (iii)
      shall, for so long as this Warrant is outstanding, have authorized and reserved, free from preemptive rights, three (3) times the number
      of shares of Common Stock into which the Warrants are then exercisable into to provide for the exercise of the rights represented by
      this Warrant (without regard to any limitations on exercise).

   

  5. WARRANT
        HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall not entitle
      the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained in this Warrant shall
      be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as
      a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

   

   6. REISSUANCE.

   

  (a) Lost,
        Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as to indemnity
      or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new
      Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

   

  (b) Issuance
        of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
      shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which is the
      same as the Issuance Date.

   

  7. TRANSFER.
      This Warrant shall be binding upon the Company and its successors and assigns, and shall inure to be the benefit of the Holder and
      its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the Company
      hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior signed
      written consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment or transfer
      shall be null and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant or any of the
      severable rights and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned by Holder to a
      third party, in whole or in part, without the need to obtain the Company’s consent thereto.

   

  
  
    6

  

  
     

  

  
   

  

  8. NOTICES.
      Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
      with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written notice (i) immediately
      upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment and (ii) at least 20
      days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
      the shares of Common Stock, (B) with respect to any grants, issuances or sales of any stock or other securities directly or indirectly
      convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata to the holders of shares of Common
      Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each
      case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.

   

  9. AMENDMENT
        AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either retroactively
      or prospectively) only with the written consent of the Company and the Holder.

   

  10. GOVERNING
        LAW AND VENUE. This Warrant shall be governed by and construed in accordance with the laws of the State of Nevada without regard
      to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by
      this Warrant shall be brought only in the state courts located in the Commonwealth of Massachusetts or federal courts located in the
      Commonwealth of Massachusetts. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action
      instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
      EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY
        DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT ENTERED INTO IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT, OR ANY TRANSACTION
        CONTEMPLATED HEREBY OR THEREBY. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s
      fees and costs. In the event that any provision of this Warrant or any other agreement delivered in connection herewith is invalid or
      unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may
      conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
      or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby
      irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with
      this Warrant or any other transaction document entered into in connection with this Warrant by mailing a copy thereof via registered
      or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under the
      Purchase Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
      herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

   

  11. ACCEPTANCE.
      Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.

   

  

  
  
    7

  

  
     

  

  
   

  12. CERTAIN
        DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

   

   (a) [Intentionally Omitted].

   

  

  (b)
      “Closing Sale Price” means, for any security as of any date, (i) the last closing trade price for such security
      on the Principal Market, as reported by Quotestream or other similar quotation service provider designated by the Holder, or, if the
      Principal Market begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade
      price of such security prior to 4:00 p.m., New York time, as reported by Quotestream or other similar quotation service provider
      designated by the Holder, or (ii) if the foregoing does not apply, the last trade price of such security in the over-the-counter
      market for such security as reported by Quotestream or other similar quotation service provider designated by the Holder, or (iii)
      if no last trade price is reported for such security by Quotestream or other similar quotation service provider designated by the
      Holder, the average of the bid and ask prices of any market makers for such security as reported by Quotestream or other similar
      quotation service provider designated by the Holder. If the Closing Sale Price cannot be calculated for a security on a particular
      date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually
      determined by the Company and the Holder. All such determinations to be appropriately adjusted for any stock dividend, stock split,
      stock combination or other similar transaction during the applicable calculation period.

   

  (c) “Common
        Stock” means the Company’s common stock, par value $0.0001, and any other class of securities into which such securities
      may hereafter be reclassified or changed.

   

  (d)
      “Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire
      at any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that
      is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
      Stock.

   

  (e)
      “Person” and “Persons” means an individual, a limited liability company, a partnership, a
      joint venture, a corporation, a trust, an unincorporated organization, any other entity and any governmental entity or any
      department or agency thereof.

   

  (f)
      “Principal Market” means the principal securities exchange or trading market where such Common Stock is listed or
      quoted, including but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital
      Market), or the NYSE American, or any successor to such markets.

   

  (g)
      “Market Price” means the highest traded price of the Common Stock during the one hundred and fifty Trading
      Days prior to the date of the respective Exercise Notice.

   

  (h)
      “Trading Day” means any day on which the Common Stock is listed or quoted on its Principal Market, provided,
      however, that if the Common Stock is not then listed or quoted on any Principal Market, then any calendar day.

   

  *
      * * * * * *

   

  
  
    8

  

  
     

  

  
   

  IN
      WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

   

  

  		GZ6G TECHNOLOGIES CORP.

  

   

  	 	 
	 	Name:	
          William Smith
        

  

  

  

  	 	Title:	
          Chief Executive Officer

   

  
  
     

  

  
     

  

  
   

  EXHIBIT
        A

   

  EXERCISE
      NOTICE

   

  (To
      be executed by the registered holder to exercise this Common Stock Purchase Warrant)

   

  THE
      UNDERSIGNED holder hereby exercises the right to purchase                              of the shares of Common Stock (“Warrant Shares”) of
      GZ6G TECHNOLOGIES CORP., a Nevada corporation (the “Company”), evidenced by the attached copy of the Common Stock
      Purchase Warrant (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective
      meanings set forth in the Warrant.

   

  	1.	Form of Exercise Price. The Holder intends that payment of the Exercise Price
            shall be made as (check one):

   

  		☐	a cash exercise with respect to                           Warrant Shares; or

   

  		☐	by cashless exercise pursuant to the Warrant.

   

  	2.	Payment of Exercise Price. If cash exercise is selected
            above, the holder shall pay the applicable Aggregate Exercise Price in the sum of $                      to the Company in accordance with the terms of the Warrant.

   

  	3.	Delivery of Warrant Shares. The Company shall deliver to the
            holder                                 Warrant Shares in accordance with the terms of the Warrant.

   

  

  	Date:                                        	 	 

   

  

  	 	 
	 	(Print
          Name of Registered Holder)

   

  	 	By:	 
	 	Name:	 
	 	 Title:	 

   

  
  
     

  

  
     

  

  
   

  EXHIBIT
        B

   

  ASSIGNMENT
      OF WARRANT

   

  (To
      be signed only upon authorized transfer of the Warrant)

   

  FOR
      VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers unto                           the right to purchase                         shares of common
      stock of GZ6G TECHNOLOGIES CORP., to which the within Common Stock Purchase Warrant relates and appoints                , as attorney-in-fact,
      to transfer said right on the books of GZ6G TECHNOLOGIES CORP. with full power of substitution and re-substitution in the premises. By
      accepting such transfer, the transferee has agreed to be bound in all respects by the terms and conditions of the within Warrant.

    

  

  	Dated:                                   	 
	 	 
	 	(Signature)
          *
	 	 
	 	 
	 	(Name)
	 	 
	 	 
	 	(Address)
	 	
	 	 
	 	(Social Security or Tax Identification No.)

   

  *
      The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase Warrant
      in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership,
      trust or other entity, please indicate your position(s) and title(s) with such entity.Exhibit 10.12

   

  AMENDMENT #1 TO THE COMMON STOCK PURCHASE

  WARRANT ISSUED ON NOVEMBER 10, 2021

   

  THIS AMENDMENT #1 to
    the Warrant (as defined below) (the “Amendment”) is entered into as of December 7, 2021 (the “Effective Date”),
    by and between GZ6G Technologies Corp., a Nevada corporation (the “Company”), and Mast Hill Fund, L.P., a Delaware limited
    partnership (the “Holder”) (collectively the “Parties”).

   

  BACKGROUND

   

  

  		A.	The
          Company and Holder are the parties to that certain common stock purchase warrant for the purchase of 560,000 shares of the Company’s
          common stock issued by the Company to the Holder on November 10, 2021 (as amended from time to time, the “Warrant”); and

   

  		B.	The Parties desire to amend the Warrant as set forth expressly below.

   

  NOW THEREFORE, in consideration of the execution
    and delivery of the Amendment and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
    the Parties agree as follows:

   

   1. Section 2(b) of the Warrant shall be replaced in its entirety with the following:

   

  “(b) Anti-Dilution
      Adjustments to Exercise Price. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding,
    shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer,
    sale, grant or any option to purchase or other disposition) any Common Stock or securities (including but not limited to Common Stock
    Equivalents) entitling any person or entity (for purposes of clarification, including but not limited to the Holder pursuant to (i) any
    other security of the Company currently held by Holder or issued to Holder on or after the Issuance Date or (ii) any other agreement entered
    into between the Company and Holder (including but not limited to the Purchase Agreement)) to acquire shares of Common Stock (upon conversion,
    exercise or otherwise), at an effective price per share less than the then Exercise Price (such lower price, the “Base Share Price”
    and such issuances collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so
    issued shall at any time, whether by operation of purchase price adjustments, elimination of an applicable floor price for any reason
    in the future (including but not limited to the passage of time or satisfaction of certain condition(s)), reset provisions, floating conversion,
    exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance,
    be entitled or potentially entitled to receive shares of Common Stock at an effective price per share which is less than the Exercise
    Price at any time while such Common Stock or Common Stock Equivalents are in existence, such issuance shall be deemed to have occurred
    for less than the Exercise Price on such date of the Dilutive Issuance (regardless of whether the Common Stock or Common Stock Equivalents
    are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised
    at such Base Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base Share
    Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued, regardless of whether the Common
    Stock or Common Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii)
    actually converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder may utilize the
    Base Share Price even if the Company did not actually issue shares of its common stock at the Base Share Price under the respective Common
    stock Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common
    Stock or Common Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or applicable reset
    price, exchange price, conversion price and other pricing terms (such notice the “Dilutive Issuance Notice”). For purposes
    of clarification, regardless of whether (i) the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b) upon the occurrence
    of any Dilutive Issuance or (ii) the Holder accurately refers to the Base Share Price in the Exercise Notice, the Holder is entitled to
    receive the Base Share Price at all times on and after the date of such Dilutive Issuance. Notwithstanding the foregoing, no adjustment
    will be made under this Section 2(b) with respect to an Exempt Issuance (as defined below). An “Exempt Issuance” shall mean
    the issuance of (a) shares of Common Stock pursuant to the Company’s registration statement on Form S-1 that was declared effective
    by the SEC on September 27, 2021; or (b) shares of Common Stock pursuant to the conversion or exercise of Common Stock Equivalents issued
    by the Company prior to the Issuance Date (so long as the terms of such Common Stock Equivalents are not amended on or after the Issuance
    Date).”

   

   2. This Amendment shall be deemed part of, but shall take precedence over and supersede any provisions to the contrary contained in
    the Warrant. Except as specifically modified hereby, all of the provisions of the Warrant, which are not in conflict with the terms of this Amendment, shall remain in full force and effect.

  

   

  [Signature page to follow]

   

  

  
  
     

  

  
     

  

  
    

  IN WITNESS WHEREOF, the parties hereto have executed this Amendment
    as of the date first above written.

   

  	GZ6G Technologies Corp.	 	Mast Hill Fund, L.P.
	 	 	 	 	 
	By:	               	 	By:	              
	Name: William Smith	 	Name: Patrick Hassani
	Title: Chief Executive Officer	 	Title: Chief Investment Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]